Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06934525 · ClinicalTrials.gov registry record · NA
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
A NA study of Anxiety and Generalized Anxiety Disorder, sponsored by Bradley Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 501
- Enrollment target
- 1
- Study location
NCT06934525: Recruiting NA study of Anxiety and Generalized Anxiety Disorder, sponsored by Bradley Hospital.
NCT06934525 is a NA study of Anxiety and Generalized Anxiety Disorder that is actively recruiting participants, run by Bradley Hospital. The registered enrollment target is 501 participants, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06934525, a NA study of Anxiety and Generalized Anxiety Disorder, is actively recruiting participants, sponsored by Bradley Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 501 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test how the delivery of Cognitive Behavioral Therapy (CBT) for pediatric anxiety and OCD via different methods might increase its availability and effectiveness. CBT involves teaching the patient skills to enable them to gradually come into contact with feared situations. This process of gradually approaching feared situations is called exposure. Although CBT with exposure has the best evidence for treating anxiety disorders, not all children have equal access or respond the same way to CBT. As part of this study, patients will receive weekly CBT treatment sessions involving a combination of weekly visits with an exposure coach and one visit a month with a licensed provider (e.g., psychologist, social worker). This treatment will be delivered using one of three methods: 1) in-person (face-to-face sessions, occurring in the office and the home/community), or 2) telehealth (entirely remote sessions via web-based video conference), or 3) flexible (individualized mix of in-person and/or telehealth sessions). Eligible participants will be randomly assigned to one of these three methods. Results of this study will help determine which treatment method works best for whom. Treatment as described above will occur as part of care at partnering community care sites in Rhode Island. Providers from the following partnering community care sites will make up patient treatment teams: Blackstone Valley Community Health Care, Family Services of Rhode Island, Gateway Healthcare, Newport Mental Health, and Thrive Behavioral Health. The research study is being conducted by the Pediatric Anxiety Research Center at Brown University Health. The research team will conduct the study assessments that patients will be asked to participate in as study participants. Patients will be asked to complete assessments prior to starting treatment, at two time points during treatment, at the end of treatment, and at two timepoints 3 and 6 months following the end of t
Primary Outcome
The TPA is designed to independently solicit from youth and parents the top 3 problems they feel are most important to address in treatment. This is an idiographic measure of impairment that is driven by the individual needs and desires of the consumer. Respondents rate how much each problem bothers them from 0 ("not at all") to 10 (very, very much).
Conditions Studied
Interventions
- BEHAVIORAL Team-delivered, exposure-based CBT
Study Locations (1)
Rhode Island
- Bradley Hospital - East Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 501 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2029-08-01 |
| Phase | NA |
What NCT06934525 shows while recruiting
NCT06934525 is an interventional study that assigns participants to a tested intervention. The registered 501 participants enrollment target is mid-sized for trials with a published cap, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (14% higher).
The record links to 10 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Team-delivered, exposure-based CBT is the first listed.
NCT06934525 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06934525 about?
NCT06934525 is a clinical study titled "Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings". The purpose of this study is to test how the delivery of Cognitive Behavioral Therapy (CBT) for pediatric anxiety and OCD via different methods might increase its availability and effectiveness. CBT involves teaching the patient skills to enable them to gradually come into contact with feared situat...
What is the current status of trial NCT06934525?
This trial is currently recruiting. It is a NA study. The enrollment target is 501 participants. The study started on 2025-11-01. Estimated completion is 2029-08-01.
What conditions does trial NCT06934525 study?
This clinical trial studies the following conditions: Anxiety, Generalized Anxiety Disorder, Anxiety Disorder, OCD, Obsessive Compulsive Disorder (OCD).
What interventions are being tested in trial NCT06934525?
The interventions under investigation include: Team-delivered, exposure-based CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT06934525?
This trial is sponsored by Bradley Hospital, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06934525 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06934525's enrollment target sits among peer trials
501 30th of 364 higher than 335 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04442022 · 501 participants · Phase 2
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT05646381 · 502 participants · Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- NCT05897632 · 502 participants · NA
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI